Literature DB >> 33817210

Analysis of SEC24D Gene in Breast Cancer Based on UALCAN Database.

Zhi Liu1, Jing Zhou2, Zhibao Wang3, Zhiqiang Zhou3.   

Abstract

OBJECTIVE: To analyze the expression and its clinical significance of the SEC24D gene in breast cancer.
METHODS: The dataset of breast cancer were searched in the UALCAN database, and the data obtained were mined and combined with literature analysis.
RESULTS: The mRNA expression of the SEC24D gene in breast cancer tissues was significantly higher than that of breast normal tissues from the UALCAN database (P < 0.05). The promoter methylation levels of the SEC24D gene in breast cancer tissues were lower than that of breast normal tissues (P < 0.05). Survival analysis showed that the relapse-free survival of breast cancer patients with a higher expression of SEC24D gene was significantly worse than those patients with a lower expression of SEC24D (P < 0.05).
CONCLUSION: The SEC24D gene has a high expression in breast cancer tissues and its expression level was related to the prognosis of breast cancer patients.
© 2019 Zhi Liu et al. published by De Gruyter.

Entities:  

Keywords:  Breast cancer; Prognosis; SEC24D; UALCAN

Year:  2019        PMID: 33817210      PMCID: PMC7874789          DOI: 10.1515/biol-2019-0080

Source DB:  PubMed          Journal:  Open Life Sci        ISSN: 2391-5412            Impact factor:   0.938


  16 in total

Review 1.  Key cancer cell signal transduction pathways as therapeutic targets.

Authors:  Roberto Bianco; Davide Melisi; Fortunato Ciardiello; Giampaolo Tortora
Journal:  Eur J Cancer       Date:  2006-01-11       Impact factor: 9.162

2.  Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.

Authors:  Mumtahena Rahman; Laurie K Jackson; W Evan Johnson; Dean Y Li; Andrea H Bild; Stephen R Piccolo
Journal:  Bioinformatics       Date:  2015-07-24       Impact factor: 6.937

3.  Osh proteins regulate COPII-mediated vesicular transport of ceramide from the endoplasmic reticulum in budding yeast.

Authors:  Kentaro Kajiwara; Atsuko Ikeda; Auxiliadora Aguilera-Romero; Guillaume A Castillon; Satoshi Kagiwada; Kentaro Hanada; Howard Riezman; Manuel Muñiz; Kouichi Funato
Journal:  J Cell Sci       Date:  2013-11-08       Impact factor: 5.285

4.  Hedgehog Signaling Activation in Hepatic Stellate Cells Promotes Angiogenesis and Vascular Mimicry in Hepatocellular Carcinoma.

Authors:  Wei Li; Shuanlin Miao; Manyuan Miao; Renshuan Li; Xiaopeng Cao; Kun Zhang; Genzuan Huang; Bin Fu
Journal:  Cancer Invest       Date:  2016-09-22       Impact factor: 2.176

5.  Laparoscopic versus open hepatectomy for hepatocellular carcinoma: long-term outcomes.

Authors:  Xiaoxin Jiang; Lian Liu; Qiugui Zhang; Yan Jiang; Jufang Huang; Hui Zhou; Leping Zeng
Journal:  J BUON       Date:  2016 Jan-Feb       Impact factor: 2.533

Review 6.  Cancer treatment and survivorship statistics, 2014.

Authors:  Carol E DeSantis; Chun Chieh Lin; Angela B Mariotto; Rebecca L Siegel; Kevin D Stein; Joan L Kramer; Rick Alteri; Anthony S Robbins; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-06-01       Impact factor: 508.702

7.  The decrease in breast-cancer incidence in 2003 in the United States.

Authors:  Peter M Ravdin; Kathleen A Cronin; Nadia Howlader; Christine D Berg; Rowan T Chlebowski; Eric J Feuer; Brenda K Edwards; Donald A Berry
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

Review 8.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

Authors:  Katarzyna Tomczak; Patrycja Czerwińska; Maciej Wiznerowicz
Journal:  Contemp Oncol (Pozn)       Date:  2015

9.  CREB3L2-mediated expression of Sec23A/Sec24D is involved in hepatic stellate cell activation through ER-Golgi transport.

Authors:  Shotaro Tomoishi; Shinichi Fukushima; Kentaro Shinohara; Toshiaki Katada; Kota Saito
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

10.  COPII - a flexible vesicle formation system.

Authors:  Elizabeth A Miller; Randy Schekman
Journal:  Curr Opin Cell Biol       Date:  2013-05-20       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.